Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-02-03 @ 1:39 AM
Study NCT ID:
NCT02437318
Status:
COMPLETED
Last Update Posted:
2025-02-13
First Post:
2015-04-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-22
First Submit QC Date:
None
Study First Post Date:
2015-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-17
Results First Submit QC Date:
None
Results First Post Date:
2019-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-07-26
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-10
Last Update Post Date:
2025-02-13
Last Update Post Date Type:
ACTUAL